Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  FUJIFILM Holdings Corp    4901   JP3814000000

FUJIFILM HOLDINGS CORP (4901)
Mes dernières consult.
Most popular
Report
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

FUJIFILM : Launches Eluxeo and Sets New Standard in Image Enhanced Endoscopy

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:31pm CET

WAYNE, N.J., Oct. 12 -- Fujifilm USA issued the following news:

FUJIFILM Medical Systems U.S.A. Inc.,- Endoscopy today introduced ELUXEO(TM), a next-generation endoscopic video imaging system to its portfolio. The processor features 4 LED Multi-Light Technology to enhance visualization of areas of interest and mucosal surfaces in the gastrointestinal tract.

"Fujifilm continues to push the boundaries of innovation through the development of our ELUXEO platform. Providing physicians with the tools they need to enhance results, ELUXEO fulfills the need for enhanced visualization in endoscopy," said Keiichi Nagata, Division President, FUJIFILM Medical Systems U.S.A., Inc - Endoscopy.

The 4 LED Multi-Light Technology, developed to achieve optimal results in illumination, includes White Light as well as the new special light observation modes BLI (Blue Light Imaging) and LCI(R) (Linked Color Imaging). BLI outputs a high intensity ratio of blue-violet light, developed for high contrast imaging of microvessels. LCI is developed to intensify differences in red coloration for enhanced mucosal visualization through the use of advanced image processing technology. Observation modes can be switched using the scope button to toggle between White Light, BLI and LCI views.

Equipped with extended lamp life expectancy and an intuitive user interface, ELUXEO is setting a new standard in endoscopic imaging. Fujifilm will unveil ELUXEO this month at the World Congress of Gastroenterology at ACG 2017 on October 13-18 at the Orange County Convention Center in Orlando, Florida.

To learn more visit www.fujifilmendoscopy.com or visit booth #1201 at ACG.

Targeted News Service, source News Service

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FUJIFILM HOLDINGS CORP
12/11 FUJIFILM : Acuity investment sparks a year of growth for Art & Servei
12/07 FUJIFILM : Partners With Fight Colorectal Cancer as a Sponsor of 'One Million St..
12/06 FUJIFILM : LOGO Werbetechnik celebrates a year of increased quality and producti..
12/02 FUJIFILM : MILITARY $143,100 Federal Contract Awarded to Fuji Xerox
12/01 FUJIFILM : The best Fujifilm Instax Mini deals pre-Black Friday 2017
12/01 FUJIFILM : Announces Fujifilm Masterpiece Award Winners
11/30 FUJIFILM : Introduces TCO Calculator
11/30 FUJIFILM : Announces Launch of New Fujifilm X Raw Studio Conversion System
11/30 FUJIFILM : launches a new RAW conversion system “FUJIFILM X RAW STUDIO&rdq..
11/30 FUJIFILM : New firmware updates for FUJIFILM X-Pro2, X-T2 X100F, X-T20 coming so..
More news
News from SeekingAlpha
10/31 FUJIFILM Holdings Corp. ADR 2018 Q2 - Results - Earnings Call Slides
10/12 FDA OKs first seven tesla MRI system in U.S.
06/20 Think First Before Trying To Find The Next Superstock Like Amazon
03/03 Fujifilm's Long Transformation Process Heading In The Right Direction
03/03 FujiFilm's biologics unit prevails over AbbVie in UK over Humira dosing paten..
Financials ( JPY)
Sales 2018 2 470 B
EBIT 2018 -
Net income 2018 133 B
Finance 2018 280 B
Yield 2018 1,65%
P/E ratio 2018 15,20
P/E ratio 2019 14,55
EV / Sales 2018 0,85x
EV / Sales 2019 0,81x
Capitalization 2 383 B
Chart FUJIFILM HOLDINGS CORP
Duration : Period :
FUJIFILM Holdings Corp Technical Analysis Chart | 4901 | JP3814000000 | 4-Traders
Technical analysis trends FUJIFILM HOLDINGS CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 5 007  JPY
Spread / Average Target 8,2%
EPS Revisions
Managers
NameTitle
Shigetaka Komori Chairman & Group Chief Executive Officer
Kenji Sukeno President, Group COO & Representative Director
Shigenobu Inenaga Head-Finance, Accounting & Business Administration
Yuzo Toda Director & Chief Technology Officer
Norio Shibata Director, Executive Officer & Head-IT Systems
Sector and Competitors
1st jan.Capitalization (M$)
FUJIFILM HOLDINGS CORP6.62%20 999
CANON INC32.71%51 167
SEIKO EPSON CORPORATION11.08%9 559
BROTHER INDUSTRIES LTD33.93%6 556
KONICA MINOLTA INC-4.06%4 842
PITNEY BOWES INC.-30.74%2 002